Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II study
- Rodriguez-Vida, A.
- Valderrama, B.P.
- Castellano, D.
- Pinto, A.
- Mellado, B.
- Puente, J.
- Climent, M.A.
- Domenech, M.
- Vazquez, F.
- Perez-Gracia, J.L.
- Bonfill, T.
- Morales-Barrera, R.
- Gonzalez-Billalabeitia, E.
- Garcia-del-Muro, X.
- Maroto, P.
- Navarro-Gorro, N.
- Juanpere, N.
- Juan, O.
- Bellmunt, J.
Revista:
ESMO Open
ISSN: 2059-7029
Any de publicació: 2024
Volum: 9
Número: 9
Tipus: Article